The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes.
 
Nilay M Gandhi
No Relationships to Disclose
 
Alexander S Baras
No Relationships to Disclose
 
Enrico Munari
No Relationships to Disclose
 
Sheila Faraj
No Relationships to Disclose
 
Leonardo O Reis
No Relationships to Disclose
 
Jen-Jane Liu
No Relationships to Disclose
 
Max Kates
No Relationships to Disclose
 
Mohammad Hoque
No Relationships to Disclose
 
David Berman
No Relationships to Disclose
 
Noah M. Hahn
Honoraria - D3 Oncology Solutions
Speakers' Bureau - Medivation
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Dendreon (Inst); Fluidigm (Inst); Genentech/Roche (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bionomics; Millennium
 
Mario A. Eisenberger
Honoraria - Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ipsen
Research Funding - Genentech; Sanofi; Tokai Pharmaceuticals
Travel, Accommodations, Expenses - Astellas Pharma; Bayer
 
George J. Netto
No Relationships to Disclose
 
Mark Schoenberg
No Relationships to Disclose
 
Trinity Bivalacqua
No Relationships to Disclose